The Global Ependymoma Drug Market Is Estimated To Propelled By Emergence Of Targeted Immunotherapy Combination Therapies
The global Ependymoma Drug Market is estimated to be valued at US$ 172.64 Bn in 2023 and is expected to exhibit a CAGR of 7.7% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.